These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 33030089)

  • 21. Treatment of comorbid migraine and temporomandibular disorders: a factorial, double-blind, randomized, placebo-controlled study.
    Goncalves DA; Camparis CM; Speciali JG; Castanharo SM; Ujikawa LT; Lipton RB; Bigal ME
    J Orofac Pain; 2013; 27(4):325-35. PubMed ID: 24171182
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Polymorphisms in COMT, ADRB2 and HTR1A genes are associated with temporomandibular disorders in individuals with other arthralgias.
    Bonato LL; Quinelato V; de Felipe Cordeiro PC; Vieira AR; Granjeiro JM; Tesch R; Casado PL
    Cranio; 2021 Jul; 39(4):351-361. PubMed ID: 31264537
    [No Abstract]   [Full Text] [Related]  

  • 23. The impact of catechol-O-methyltransferase SNPs and haplotypes on treatment response phenotypes in major depressive disorder: a case-control association study.
    Kocabas NA; Faghel C; Barreto M; Kasper S; Linotte S; Mendlewicz J; Noro M; Oswald P; Souery D; Zohar J; Massat I
    Int Clin Psychopharmacol; 2010 Jul; 25(4):218-27. PubMed ID: 20531207
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Is catechol-O-methyltransferase gene associated with temporomandibular disorders? A systematic review and meta-analysis.
    Brancher JA; Bertoli FMP; Michels B; Lopes-Faturri A; Pizzatto E; Losso EM; Orsi JS; Feltrin de Souza J; Küchler EC; Wambier LM
    Int J Paediatr Dent; 2021 Jan; 31(1):152-163. PubMed ID: 32961632
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Associations of catechol-O-methyltransferase (rs4680) single nucleotide polymorphisms with opioid use and dose among adults with chronic pain.
    Hooten WM; Biernacka JM; O'Brien TG; Cunningham JM; Black JL
    Pain; 2019 Jan; 160(1):263-268. PubMed ID: 30211780
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Catechol-o-methyltransferase polymorphisms predict opioid consumption in postoperative pain.
    Candiotti KA; Yang Z; Buric D; Arheart K; Zhang Y; Rodriguez Y; Gitlin MC; Carvalho E; Jaraba I; Wang L
    Anesth Analg; 2014 Nov; 119(5):1194-200. PubMed ID: 25185591
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genomics and the new perspectives for temporomandibular disorders.
    Meloto CB; Serrano PO; Ribeiro-DaSilva MC; Rizzatti-Barbosa CM
    Arch Oral Biol; 2011 Nov; 56(11):1181-91. PubMed ID: 21536254
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Associations between catechol-O-methyltransferase (COMT) genotypes at rs4818 and rs4680 and gene expression in human dorsolateral prefrontal cortex.
    Dean B; Parkin GM; Gibbons AS
    Exp Brain Res; 2020 Feb; 238(2):477-486. PubMed ID: 31960101
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The opioid receptor mu 1 (OPRM1) rs1799971 and catechol-O-methyltransferase (COMT) rs4680 as genetic markers for placebo analgesia.
    Aslaksen PM; Forsberg JT; Gjerstad J
    Pain; 2018 Dec; 159(12):2585-2592. PubMed ID: 30130297
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Catechol-O-methyltransferase gene polymorphism and vulvar pain in women with vulvodynia.
    Patanwala IY; Lamvu G; Ledger WJ; Witzeman K; Marvel R; Rapkin A; Bongiovanni AM; Feranec J; Witkin SS
    Am J Obstet Gynecol; 2017 Apr; 216(4):395.e1-395.e6. PubMed ID: 27780702
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genetic variation in the catechol-O-methyltransferase (COMT) gene and morphine requirements in cancer patients with pain.
    Rakvåg TT; Ross JR; Sato H; Skorpen F; Kaasa S; Klepstad P
    Mol Pain; 2008 Dec; 4():64. PubMed ID: 19094200
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Catechol-oxide-methyltransferase (COMT rs4680:G>A) gene polymorphism does not affect analgesics’ demand after elective hip replaceme.
    Białecka M; Jurewicz A; Cięszczyk P; Machoy-Mokrzyńska A; Kurzawski M; Leźnicka K; Dziedziejko V; Safranow K; Droździk M; Bohatyrewicz A
    Genetika; 2016 May; 52(5):616-20. PubMed ID: 29368490
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Influence of variation in the catechol-O-methyltransferase gene on the clinical outcome after lumbar spine surgery for one-level symptomatic disc disease: a report on 176 cases.
    Rut M; Machoy-Mokrzyńska A; Ręcławowicz D; Słoniewski P; Kurzawski M; Droździk M; Safranow K; Morawska M; Białecka M
    Acta Neurochir (Wien); 2014 Feb; 156(2):245-52. PubMed ID: 24178190
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Catechol-O-methyltransferase gene polymorphism and chronic human pain: a systematic review and meta-analysis.
    Tammimäki A; Männistö PT
    Pharmacogenet Genomics; 2012 Sep; 22(9):673-91. PubMed ID: 22722321
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Catechol-O-methyltransferase (COMT) gene variants predict response to bupropion therapy for tobacco dependence.
    Berrettini WH; Wileyto EP; Epstein L; Restine S; Hawk L; Shields P; Niaura R; Lerman C
    Biol Psychiatry; 2007 Jan; 61(1):111-8. PubMed ID: 16876132
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Catechol-O-methyltransferase val158met polymorphism predicts placebo effect in irritable bowel syndrome.
    Hall KT; Lembo AJ; Kirsch I; Ziogas DC; Douaiher J; Jensen KB; Conboy LA; Kelley JM; Kokkotou E; Kaptchuk TJ
    PLoS One; 2012; 7(10):e48135. PubMed ID: 23110189
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Facial pain with localized and widespread manifestations: separate pathways of vulnerability.
    Slade GD; Smith SB; Zaykin DV; Tchivileva IE; Gibson DG; Yuryev A; Mazo I; Bair E; Fillingim R; Ohrbach R; Greenspan J; Maixner W; Diatchenko L
    Pain; 2013 Nov; 154(11):2335-2343. PubMed ID: 23867732
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genome-wide association reveals contribution of MRAS to painful temporomandibular disorder in males.
    Smith SB; Parisien M; Bair E; Belfer I; Chabot-Doré AJ; Gris P; Khoury S; Tansley S; Torosyan Y; Zaykin DV; Bernhardt O; de Oliveira Serrano P; Gracely RH; Jain D; Järvelin MR; Kaste LM; Kerr KF; Kocher T; Lähdesmäki R; Laniado N; Laurie CC; Laurie CA; Männikkö M; Meloto CB; Nackley AG; Nelson SC; Pesonen P; Ribeiro-Dasilva MC; Rizzatti-Barbosa CM; Sanders AE; Schwahn C; Sipilä K; Sofer T; Teumer A; Mogil JS; Fillingim RB; Greenspan JD; Ohrbach R; Slade GD; Maixner W; Diatchenko L
    Pain; 2019 Mar; 160(3):579-591. PubMed ID: 30431558
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An opposite-direction modulation of the COMT Val158Met polymorphism on the clinical response to intrathecal morphine and triptans.
    Cargnin S; Magnani F; Viana M; Tassorelli C; Mittino D; Cantello R; Sances G; Nappi G; Canonico PL; Genazzani AA; Raffaeli W; Terrazzino S
    J Pain; 2013 Oct; 14(10):1097-106. PubMed ID: 23773341
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The association of genetic polymorphisms in serotonin transporter and catechol-O-methyltransferase on temporomandibular disorders and anxiety in adolescents.
    Brancher JA; Spada PP; Meger MN; Fatturri AL; Dalledone M; de Paiva Bertoli FM; Deeley K; Scariot R; Vieira AR; Küchler EC; de Souza JF
    J Oral Rehabil; 2019 Jul; 46(7):597-604. PubMed ID: 30811655
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.